EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TYK2 : p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels

Maristella Steri, Valeria Orrù, Carlo Sidore, Antonella Mulas iD, Maristella Pitzalis, Fabio Busonero, Andrea Maschio, Valentina Serra, Mariano Dei, Sandra Lai, Francesca Virdis, Monia Lobina und 12 weitere

Immunology · 2025

DOI: 10.1111/imm.13902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Maristella Steri und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetic and Biomedical Research (IRGB), Italian National Research Council (CNR), Monserrato, Sardinia, Italy. Hauptthemen laut MEDLINE: TYK2 Kinase, Autoimmunity, Autoimmune Diseases, B-Lymphocytes. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, Fondazione Italiana Sclerosi Multipla (FISM), financed or co-financed with the '5 per mille' public funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The TYK2 :p.Pro1104Ala (rs34536443) hypomorph variant has been associated with protection against numerous autoimmune disorders. Thus, its mechanism of action becomes of great interest. Here, consistent with the participation of activated immune cells in autoimmunity, we show that the variant regulates the levels of immune cells at a human, general population level and is associated particularly with higher levels of T and B lymphocytes, especially the naïve (non‐activated) compartment. Also, consistent with a protective function in autoimmunity, the level of regulatory CD4+ T cells was increased. Thus, this variant decreases immune activation thereby protecting from autoimmunity. Our work links the cellular mechanism regulated by the TYK2 :p.Pro1104Ala variant to autoimmunity protection and supports TYK2 as a therapeutic target in autoimmunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TYK2 KinaseAutoimmunityAutoimmune DiseasesB-LymphocytesHumansLymphocyte ActivationFemaleMale

Stichwörter der Autor:innen

TYK2autoimmunityimmune cell levelsimmunophenotypingnaïve cells

Substanzen

TYK2 KinaseTYK2 protein, human

Autor:innen und Institutionen

  • Institute of Genetic and Biomedical Research (IRGB), Italian National Research Council (CNR), Monserrato, Sardinia, Italy.
  • Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
  • Laboratory of Genetics and Genomics, National Institute on Aging (NIA), National Institutes of Health (NIH), Baltimore, Maryland, USA.

ORCID-Profile: Antonella Mulas, Magdalena Zoledziewska

Förderung

  • NIDA NIH HHS
  • Fondazione Italiana Sclerosi Multipla (FISM)
  • financed or co-financed with the '5 per mille' public funding

Zitieren

APA

Steri, M., Orrù, V., Sidore, C., Mulas, A., Pitzalis, M., Busonero, F., Maschio, A., Serra, V., Dei, M., Lai, S., Virdis, F., Lobina, M., Loizedda, A., Marongiu, M., Masala, M., Floris, M., Curreli, N., Balaci, L., Loi, F., …, & Zoledziewska, M. (2025). TYK2 : p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels. Immunology. https://doi.org/10.1111/imm.13902

Vancouver

Steri M, Orrù V, Sidore C, Mulas A, Pitzalis M, Busonero F, et al. TYK2 : p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels. Immunology. 2025. doi:10.1111/imm.13902

BibTeX
@article{Steri2025,
  author = {Steri, Maristella and Orrù, Valeria and Sidore, Carlo and Mulas, Antonella and Pitzalis, Maristella and Busonero, Fabio and Maschio, Andrea and Serra, Valentina and Dei, Mariano and Lai, Sandra and Virdis, Francesca and Lobina, Monia and Loizedda, Annalisa and Marongiu, Michele and Masala, Marco and Floris, Matteo and Curreli, Nicolò and Balaci, Lenuta and Loi, Francesco and Pilia, Maria Grazia and Delitala, Alessandro and Fiorillo, Edoardo and Schlessinger, David and Zoledziewska, Magdalena},
  title = {TYK2 : p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels},
  journal = {Immunology},
  year = {2025},
  doi = {10.1111/imm.13902}
}
Kostenlos starten →